SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is rallying as the community intently focuses on whether the company will decline to match a recently deemed superior offer for Warner Bros. Discovery, with many investors hoping this avoids substantial debt and regulatory obstacles, potentially triggering further upside as the crucial decision looms.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

The RAGE CRYPTO community is rallying with fierce conviction, actively 'bag working' and generating 'dank memes' to assert the token's 'OG meme' status and potential for significant growth, even as market conditions test other projects.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending heavily as investors keenly await its Q4 2025 earnings report, anticipating updates on new Matrix-M adjuvant partnerships, especially in oncology, following its recent Pfizer deal. The community is actively discussing a potential short squeeze fueled by high short interest and perceived undervaluation, alongside hopes for a strategic pivot to unlock its platform technology's broader value.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance (PSKY) is heavily discussed as Warner Bros. Discovery (WBD) considers its revised, potentially superior takeover bid, prompting community debate over whether PSKY is making a transformative move or incurring excessive debt, and if Netflix will counter-bid or accept a breakup fee.

Duolingo, Inc. is a language-learning website and mobile application, which engages in the development of a free language learning website and crowd sourced text translation platform. It offers Duolingo for Schools, a free, web-based tool that aims to make it easier for teachers to use the Duolingo platform in a structured learning environment, and English Test, an online, on-demand assessment of English proficiency. The company was founded by Luis von Ahn and Severin Hacker in 2011 and is headquartered in Pittsburgh, PA.

Duolingo Inc - Ordinary Shares - Class A

Duolingo Inc

Duolingo is experiencing significant volatility following guidance that prioritizes user growth and AI innovation over immediate financial gains, alongside a $400M share buyback. This has ignited a fierce debate among investors regarding the company's long-term competitive moat against AI translation tools versus its potential to become an education super-app.

Block, Inc. engages in creating ecosystems for distinct customer audiences. It operates through the Square and Cash App segments. The Square segment provides payment services, software solutions, hardware, and financial services to sellers. The Cash App segment includes the financial tools available to individuals within the mobile Cash App, including peer-to-peer payments, bitcoin and stock investments. It also includes Cash App Card, which is linked to customer stored balances that customers can use to pay for purchases or withdraw funds from an ATM. The company was founded by Jack Patrick Dorsey and James Morgan McKelvey in February 2009 and is headquartered in Oakland, CA.

Block Inc - Ordinary Shares - Class A

Block Inc

Block Inc. is surging after announcing a significant workforce reduction and restructuring towards an "AI-first" strategy, coinciding with strong Q4 results. The market is cheering these aggressive cost-cutting measures, sparking community debate over the ethics of rewarding mass layoffs and their implications for the broader tech sector's efficiency through AI.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is trending after its latest earnings report revealed record annual revenue, a GAAP profit, and robust 2026 guidance, sparking strong bullish sentiment among investors. The community is actively debating the potential for a short squeeze given high short interest, though some members remain cautious about the company's long-term profitability trajectory.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Terra Luna Classic (LUNC) is trending as the community views Do Kwon's sentencing as a pivotal moment for its potential revival and clearer path forward, alongside consistent token burns by Binance and the broader crypto market's anticipation of an incoming "Clarity Act" to drive a new bull cycle.

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell Technologies is trending due to its recent strong earnings, record-setting AI-optimized server backlog, and an optimistic future outlook, fueling significant bullish sentiment among investors who see it as a key player in the AI infrastructure boom despite ongoing discussions around PC market pressures.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab's Q4 earnings report is driving conversation with strong revenue growth and backlog, though the Neutron rocket's first launch is now targeted for late 2026. Community discussion highlights numerous new launch contracts and strategic acquisitions, particularly strengthening RKLB's position in the defense sector and solidifying its role as a diversified space systems provider.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Candel Therapeutics (NASDAQ:CADL) Director Paul Manning Purchases 550,458 Shares

Candel Therapeutics, Inc. (NASDAQ:CADL - Get Free Report) Director Paul Manning bought 550,458 shares of the firm's stock in a transaction dated Monday, February 23rd. The stock was bought at an...

Candel Therapeutics, Inc. (NASDAQ:CADL) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of Candel Therapeutics, Inc. (NASDAQ:CADL - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the nine brokerages that are currently covering the stock, MarketBeat...

Why Is Candel Therapeutics Stock Falling Friday?

Candel Therapeutics stock down on public offering pricing, intends to use proceeds for cancer therapies and development costs.read more...

Stock Market Today: Dow Jones, S&P 500 Futures Rise Ahead Of Q4 GDP Numbers Grail, Candel Therapeutics, Copart In Focus

U.S. stock futures rose on Friday after closing lower on Thursday. Futures of all the major benchmark indices were positive. Wall Street is waiting for the fourth-quarter GDP data, scheduled for...

<ul class="summary-bullets"><li>The $100 million equity raise is expected to fund commercialization preparations for CAN-2409 in early-stage, localized prostate cancer.</li><li>Candel also plans to use part of the funds to support the ongoing phase 3 trial of CAN-2409 in non-small cell lung cancer.</li><li>RTW is set to receive a tiered single-digit percentage of U.S. net sales, subject to a cap.</li></ul>Shares of Candel Therapeutics, Inc. (CADL) fell 14% in extended trading on Thursday, after the company outlined plans for a $100 million public stock offering, outweighing a $100 million royalty funding agreement announced the same day.<h2 class="st-heading-2">Candel Launches $100M Public Offering</h2>Candel said it has launched an underwritten public offering of $100 million of its common stock. The underwriters have also been granted a 30-day option to purchase up to an additional $15 million in shares on the same terms.According to the company, the proceeds will go toward preparing for the potential launch of Aglatimagene Besadenovec, also known as CAN-2409, in early-stage, localized prostate cancer. This includes medical affairs, launch readiness and other commercialization-related work. Candel also plans to use part of the funds to support the ongoing phase 3 trial of CAN-2409 in non-small cell lung cancer.<h2 class="st-heading-2">RTW Royalty Deal Adds $100M In Funding</h2>Earlier in the day, Candel separately disclosed a $100 million royalty funding agreement with funds managed by RTW Investments. The deal will support a potential U.S. launch of CAN-2409 in intermediate to high-risk localized prostate cancer.The royalty financing is tied to regulatory progress. It will become available upon approval of CAN-2409 by the U.S. Food and Drug Administration (FDA). Under the terms of the agreement, RTW would receive a tiered single-digit percentage of annual U.S. net sales of the therapy, subject to a cap.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment for CADL was ‘extremely bullish’ amid ‘extremely high’ message volume.<figure class="image"><img src="https://news.stocktwits-cdn.com/cadl_ss_png_cea4ebff8f.webp" alt="cadl ss.png" width="977" height="147"><figcaption>CADL sentiment and message volume as of February 19 | Source: Stocktwits</figcaption></figure>One user&nbsp;<a href="https://stocktwits.com/Araman44/message/645398070">said</a>, “At the end of the day, this stock has lots of potential due to its pipeline. Trade away as needed. Just don’t be surprised when it flies.”<stembedurl>https://stocktwits.com/Araman44/message/645398070</stembedurl>Another user&nbsp;<a href="https://stocktwits.com/CO145/message/645397862">said</a> they want to see RTW participate in the deal alongside other “prominent” biotech investors, including Manning and “high-quality” institutional funds such as T. Rowe Price. “If we see this, the stock will perform well finally. I do not want to see CVI, Susquehanna, or any of these low-quality players,” they added.<stembedurl>https://stocktwits.com/CO145/message/645397862</stembedurl>CADL stock has risen 5% so far this year.For updates and corrections, email newsroom[at]stocktwits[dot]com.

CADL stock has risen 5% so far this year. (Photo credit: Getty Images)

Why CADL Stock Plunged Nearly 15% In After-Hours Trading Today

Candel is pushing ahead with an equity raise and also lined up $100 million in royalty funding from RTW Investments, contingent on FDA approval of CAN-2409.

Equity

Candel Therapeutics (NASDAQ:CADL) Trading 3.9% Higher - Should You Buy?

Candel Therapeutics (NASDAQ:CADL) Trading Up 3.9% - What's Next...

Candel Therapeutics (NASDAQ:CADL) Stock Rating Lowered by Zacks Research

Zacks Research cut shares of Candel Therapeutics from a "hold" rating to a "strong sell" rating in a research note on Monday...

New Strong Sell Stocks for January 20th

DAR, CADL and DRTS have been added to the Zacks Rank #5 (Strong Sell) List on January 20, 2026.

Candel Therapeutics, Inc. (NASDAQ:CADL) Given Consensus Rating of "Moderate Buy" by Brokerages

Candel Therapeutics, Inc. (NASDAQ:CADL - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the eight ratings firms that are covering the stock, MarketBeat reports...

Candel Therapeutics, Inc. $CADL is Acorn Capital Advisors LLC's 5th Largest Position

Acorn Capital Advisors LLC boosted its position in Candel Therapeutics, Inc. (NASDAQ:CADL - Free Report) by 19.9% in the second quarter, according to the company in its most recent Form 13F filing...

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Current Price	$5.15
Prev Close	$5.18
Open	$5.18
Dividend Yield	0.00%
50-Day Moving Average	$5.77
Beta	1.31
Avg. Volume	735,250.60
PE Ratio	-9.26

52-Week High	$9.13
52-Week Low	$4.25
Market Capitalization	$284.37M
EPS (Annual)	-$1.74
Price to Book	3.55
Revenue Per Employee	$0.00

CADL
Candel Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CADL News

CADLCandel Therapeutics Inc